194 related articles for article (PubMed ID: 18360867)
1. Does gadolinium-based angiography protect against contrast-induced nephropathy?: a systematic review of the literature.
Boyden TF; Gurm HS
Catheter Cardiovasc Interv; 2008 Apr; 71(5):687-93. PubMed ID: 18360867
[TBL] [Abstract][Full Text] [Related]
2. The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure.
Saleh L; Juneman E; Movahed MR
Catheter Cardiovasc Interv; 2011 Nov; 78(5):747-54. PubMed ID: 21780275
[TBL] [Abstract][Full Text] [Related]
3. Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.
From AM; Al Badarin FJ; McDonald FS; Bartholmai BJ; Cha SS; Rihal CS
Circ Cardiovasc Interv; 2010 Aug; 3(4):351-8. PubMed ID: 20647563
[TBL] [Abstract][Full Text] [Related]
4. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
5. [Kidney and iodinated and gadolinium-based contrast agents].
Clément O; Faye N; Fournier L; Siauve N; Frija G
J Radiol; 2011 Apr; 92(4):291-8. PubMed ID: 21549885
[TBL] [Abstract][Full Text] [Related]
6. Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: An updated systematic review and meta-analysis.
Ye Z; Lu H; Su Q; Guo W; Dai W; Li H; Yang H; Li L
Medicine (Baltimore); 2017 Mar; 96(9):e6059. PubMed ID: 28248861
[TBL] [Abstract][Full Text] [Related]
7. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
[TBL] [Abstract][Full Text] [Related]
8. Use of gadolinium for carotid artery angiography and stenting in patients with renal insufficiency.
Yaganti V; Alani F; Yaganti S; Goldberg S; McCormick D
J Ren Care; 2009 Dec; 35(4):211-8. PubMed ID: 19909415
[TBL] [Abstract][Full Text] [Related]
9. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
Ledneva E; Karie S; Launay-Vacher V; Janus N; Deray G
Radiology; 2009 Mar; 250(3):618-28. PubMed ID: 19244037
[TBL] [Abstract][Full Text] [Related]
10. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.
Sam AD; Morasch MD; Collins J; Song G; Chen R; Pereles FS
J Vasc Surg; 2003 Aug; 38(2):313-8. PubMed ID: 12891113
[TBL] [Abstract][Full Text] [Related]
11. [Contrast-induced nephropathy].
Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
[TBL] [Abstract][Full Text] [Related]
12. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD
Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017
[TBL] [Abstract][Full Text] [Related]
13. Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.
Fujihara M; Kawasaki D; Shintani Y; Fukunaga M; Nakama T; Koshida R; Higashimori A; Yokoi Y;
Catheter Cardiovasc Interv; 2015 Apr; 85(5):870-7. PubMed ID: 25380326
[TBL] [Abstract][Full Text] [Related]
14. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
Tonolini M; Bianco R
Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of contrast media: an update.
ten Dam MA; Wetzels JF
Neth J Med; 2008 Nov; 66(10):416-22. PubMed ID: 19011267
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
[TBL] [Abstract][Full Text] [Related]
17. [Contrast-induced nephropathy in patients at risk of renal failure undergoing computed tomography: systematic review and meta-analysis of randomized controlled trials].
Arana E; Catalá-López F
Med Clin (Barc); 2010 Sep; 135(8):343-50. PubMed ID: 20594563
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis.
Eng J; Wilson RF; Subramaniam RM; Zhang A; Suarez-Cuervo C; Turban S; Choi MJ; Sherrod C; Hutfless S; Iyoha EE; Bass EB
Ann Intern Med; 2016 Mar; 164(6):417-24. PubMed ID: 26830055
[TBL] [Abstract][Full Text] [Related]
19. Reducing the risk of contrast-induced nephropathy: a perspective on the controversies.
Ellis JH; Cohan RH
AJR Am J Roentgenol; 2009 Jun; 192(6):1544-9. PubMed ID: 19457817
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast.
Prince MR; Arnoldus C; Frisoli JK
J Magn Reson Imaging; 1996; 6(1):162-6. PubMed ID: 8851422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
